• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    AbbVie Inc. (ABBV)

    -NYSE
    52.58 Up 0.40(0.77%) Feb 12, 4:01PM EST
    |After Hours : 52.60 Up 0.02 (0.04%) Feb 12, 7:27PM EST
    Prev Close:52.18
    Open:52.53
    Bid:52.13 x 100
    Ask:52.60 x 100
    1y Target Est:72.25
    Beta:1.59589
    Earnings Date:Apr 21 - Apr 25 (Est.)
    Day's Range:51.60 - 52.97
    52wk Range:45.45 - 71.60
    Volume:9,976,155
    Avg Vol (3m):8,969,840
    Market Cap:85.96B
    P/E (ttm):16.80
    EPS (ttm):3.13
    Div & Yield:2.28 (4.37%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 0.77%85.96B
    PFEUp 0.79%181.25B
    MRKUp 0.37%136.97B

    Key Statistics

    Forward P/E (1 yr):8.82
    P/S (ttm):3.73
    Ex-Dividend Date:13-Jan-16

    Analysts

    Annual EPS Est (Dec-16) :5.03
    Quarterly EPS Est (Mar-16) :1.13
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):0.57

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback